McKinley Carter Wealth Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$807K Sell
1,641
-737
-31% -$400K 0.05% 183
2025
Q4
$1.38M Sell
2,378
-488
-17% -$276K 0.08% 149
2025
Q3
$1.39M Sell
2,866
-278
-9% -$129K 0.07% 148
2025
Q2
$1.27M Sell
3,144
-403
-11% -$168K 0.07% 150
2025
Q1
$1.76M Sell
3,547
-55
-2% -$29.8K 0.11% 120
2024
Q4
$1.87M Sell
3,602
-562
-13% -$309K 0.11% 114
2024
Q3
$2.58M Sell
4,164
-402
-9% -$238K 0.16% 98
2024
Q2
$2.52M Sell
4,566
-1,121
-20% -$642K 0.16% 101
2024
Q1
$3.31M Sell
5,687
-9,196
-62% -$5.16M 0.22% 84
2023
Q4
$7.9M Buy
14,883
+2,021
+16% +$978K 0.58% 40
2023
Q3
$6.51M Sell
12,862
-92
-0.7% -$49K 0.52% 43
2023
Q2
$6.76M Sell
12,954
-141
-1% -$76.1K 0.51% 43
2023
Q1
$7.55M Sell
13,095
-59
-0.4% -$33.3K 0.59% 33
2022
Q4
$7.24M Sell
13,154
-121
-0.9% -$64.1K 0.61% 36
2022
Q3
$6.73M Buy
13,275
+54
+0.4% +$30.2K 0.63% 38
2022
Q2
$7.18M Sell
13,221
-177
-1% -$97.4K 0.64% 34
2022
Q1
$7.91M Sell
13,398
-6
-0% -$3.45K 0.62% 34
2021
Q4
$8.94M Sell
13,404
-347
-3% -$217K 0.67% 33
2021
Q3
$7.86M Hold
13,751
0.64% 35
2021
Q2
$6.94M Sell
13,751
-339
-2% -$160K 0.57% 38
2021
Q1
$6.43M Buy
14,090
+694
+5% +$331K 0.55% 37
2020
Q4
$6.24M Sell
13,396
-494
-4% -$232K 0.82% 32
2020
Q3
$6.13M Buy
13,890
+423
+3% +$175K 1.38% 16
2020
Q2
$4.88M Buy
13,467
+578
+4% +$194K 1.2% 18
2020
Q1
$3.65M Sell
12,889
-1,015
-7% -$320K 1.09% 19
2019
Q4
$4.52M Sell
13,904
-39
-0.3% -$11.8K 1.06% 17
2019
Q3
$4.06M Sell
13,943
-168
-1% -$48.1K 1.04% 20
2019
Q2
$4.14M Sell
14,111
-680
-5% -$187K 1.12% 18
2019
Q1
$4.05M Buy
14,791
+704
+5% +$175K 1.14% 17
2018
Q4
$3.15M Buy
14,087
+206
+1% +$48.3K 1.04% 20
2018
Q3
$3.39M Buy
13,881
+184
+1% +$42.3K 1% 23
2018
Q2
$2.84M Sell
13,697
-37
-0.3% -$7.85K 0.91% 26
2018
Q1
$2.84M Sell
13,734
-187
-1% -$39.3K 0.93% 25
2017
Q4
$2.64M Sell
13,921
-602
-4% -$115K 0.91% 25
2017
Q3
$2.75M Sell
14,523
-176
-1% -$31.9K 1.05% 22
2017
Q2
$2.56M Buy
14,699
+13
+0.1% +$2.18K 1.13% 24
2017
Q1
$2.26M Buy
14,686
+71
+0.5% +$10.9K 1.05% 31
2016
Q4
$2.06M Sell
14,615
-74
-0.5% -$10.9K 1.04% 35
2016
Q3
$2.34M Buy
14,689
+32
+0.2% +$4.93K 1.2% 26
2016
Q2
$2.17M Buy
14,657
+881
+6% +$130K 1.13% 32
2016
Q1
$1.95M Buy
13,776
+138
+1% +$18.5K 1.08% 29
2015
Q4
$1.94M Buy
13,638
+302
+2% +$40.3K 1.11% 31
2015
Q3
$1.63M Buy
13,336
+1,154
+9% +$150K 1.02% 39
2015
Q2
$1.58M Buy
12,182
+132
+1% +$17.2K 0.86% 42
2015
Q1
$1.62M Buy
12,050
+507
+4% +$65.4K 1.04% 36
2014
Q4
$1.45M Buy
11,543
+1,400
+14% +$170K 1.13% 37
2014
Q3
$1.23M Buy
10,143
+8,256
+438% +$1M 1.17% 33
2014
Q2
$223K Hold
1,887
0.24% 82
2014
Q1
$227K Sell
1,887
-2,457
-57% -$292K 0.25% 85
2013
Q4
$484K Sell
4,344
-1,760
-29% -$175K 0.47% 59
2013
Q3
$462K Sell
6,104
-55
-0.9% -$4.97K 0.55% 41
2013
Q2
$521K Buy
+6,159
New +$513K 0.79% 32

Other funds holding TMO

McKinley Carter Wealth Services's TMO Position: Q1 2026 in Review

McKinley Carter Wealth Services reduced its Thermo Fisher Scientific (TMO) stake by 31% in Q1 2026, selling an estimated $400K and leaving 1,641 shares worth $807K. The position accounts for 0.05% of the portfolio, ranked #183.

McKinley Carter Wealth Services first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.94M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • McKinley Carter Wealth Services held 1,641 shares of Thermo Fisher Scientific worth $807K as of Q1 2026.
  • McKinley Carter Wealth Services sold 737 Thermo Fisher Scientific shares in Q1 2026, an estimated $400K.
  • Thermo Fisher Scientific made up 0.05% of McKinley Carter Wealth Services's portfolio in Q1 2026, its #183 holding.
  • McKinley Carter Wealth Services first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • McKinley Carter Wealth Services's Thermo Fisher Scientific position peaked at $8.94M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on McKinley Carter Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.